CynthiaA.LynchMD

Oncology • Goodyear, AZ

Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope

Join to view full profile

Dr. Lynch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lynch's full profile

Already have an account?

Office
14200 W. Celebrate Life Way.
Goodyear, AZ 85338

Education & Training

Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
Cleveland Clinic (Florida)Residency, Internal Medicine, 2001 - 2004
Drexel University College of MedicineClass of 2001

Certifications & Licensure

AZ State Medical License 2015 - 2025
NY State Medical License 2011 - 2016
PA State Medical License 2010 - 2016
NC State Medical License 2005 - 2011
FL State Medical License 2004 - 2006
OH State Medical License 2002 - 2003
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Completed
Phase 2
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread Start of enrollment: 2018 Nov 28
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

102 citations
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
Glen J. Weiss, Jordan Waypa, Lisa Blaydorn, Jessica Coats, Kayla McGahey
British Journal of Cancer. 2017-06-27
38 citations
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
Ganesh K. Boora, Amit A. Kulkarni, Rahul Kanwar, Peter Beyerlein, Rui Qin
Journal of the Neurological Sciences. 2015-10-15
4 citations
Eosinophilic Gastro-Enteritis Associated with Protein-Losing Enteropathy and Protein C Deficiency
D L Wing-Harkins, G W Dellinger, Cynthia A. Lynch, A A Mihas
The Journal of International Medical Research. 1996-01-01